The Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)1 is the largest study in the family of trials2 3 that led to modification in guidelines4 and clinical practice in patients receiving fibrinolysis for ST-segment elevation myocardial infarction (STEMI)
Rise and fall of glycoprotein IIb-IIIa inhibitors in ST-segment elevation myocardial infarction / Di Mario, Carlo. - In: HEART. - ISSN 1468-201X. - ELETTRONICO. - 100:(2014), pp. 823-824. [10.1136/heartjnl-2013-305374]
Rise and fall of glycoprotein IIb-IIIa inhibitors in ST-segment elevation myocardial infarction
Di Mario, Carlo
2014
Abstract
The Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)1 is the largest study in the family of trials2 3 that led to modification in guidelines4 and clinical practice in patients receiving fibrinolysis for ST-segment elevation myocardial infarction (STEMI)
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Di Mario BMJ 2014 pag.823-824.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
373.09 kB
Formato
Adobe PDF
|
373.09 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
